US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 38.980
  • +0.380+0.98%
Close Jan 2 16:00 ET
  • 40.000
  • +1.020+2.62%
Post 18:18 ET
2.32BMarket Cap14.23P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 36.599M--
--2024/Q4-- / 53.523M--
--2024/Q34.675M / 1.813M--
--2024/Q24.167M / 6.667M--
--2024/Q1254.953M / 120.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 36.599M--
--2024/Q4-- / 53.523M--
--2024/Q34.675M / 1.813M--
--2024/Q24.167M / 6.667M--
--2024/Q1254.953M / 120.000M--

Unlock Free Earnings Estimates

Protagonist Therapeutics Earnings Reports

  • Protagonist Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 22:36 ET

  • Protagonist Therapeutics | 8-K: Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 7, 2024 16:15 ET

  • Protagonist Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:24 ET

  • Protagonist Therapeutics | 8-K: Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 6, 2024 07:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data